Search Results

1 - 6 of 6 items :

  • "prostate cancer" x
  • Emergency Medicine and Intensive-Care Medicine x
Clear All
Medication-Related Osteonecrosis of the Jaw: a Brief Review, Treatment and Practical Guidelines for Dentists

, Gleason DM, Murray R, et al. Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst . 2004;96:879-882. 7. Berenson JR, Hillner BE, Kyle RA, et al. American society of clinical oncology clinical practice guidelines: The role of bisphosphonates in multiple myeloma. J Clin Oncol . 2002;20:3719-3736. 8. Delmas PD. The use of bisphosphonates in the treatment of osteoporosis. Curr Opin Rheumatol . 2005;17:462-466. 9. Medical economics. Physicians

Open access
Detection of Myocardial Injury Using miRNAs Expression as Genetic Biomarkers in Acute Cardiac Care

;10:740-747. doi: 10.1631/jzus.B0920119. 6. Moore E, Bellomo R, Nichol A. Biomarkers of acute kidney injury in anesthesia, intensive care and major surgery: From the bench to clinical research to clinical practice. Minerva Anestesiol. 2010;76:425-440. 7. Devaux Y, Stammet P, Friberg H, et al. MicroRNAs: new biomarkers and therapeutic targets after cardiac arrest? Crit Care. 2015;19:54. doi: 10.1186/s13054-015-0767-2. 8. Bryant RJ, Pawlowski T, Catto JWF, et al. Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer. 2012

Open access
Left Para-Renal Castleman Disease: Case Report

REFERENCES 1. Hatano K, Fujita S, Tsujimoto Y, et al. Rare case of the hyaline vascular type of Castlemans’s disease of the kidney. International Journal of Urology . 2007;14:1098-1100. 2. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer . 1956;9:822-830. 3. Guthrie PJ, Thomas JV, Peker D, Turkbey B, Rais-Bahrami S. Perivesical unicentric Castleman disease initially suspected to be metastatic prostate cancer. Urol Ann . 2016;8:245-248. 4. Vassos N, Raptis D, Lell M, et al

Open access
Knowledge and Attitude of Dentists Regarding Patients Undergoing Bisphosphonate Treatment: a Comparative Questionnaire

-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. European Urology . 2008;54:1066-1072. 13. Badros A, Weikel D, Salama A, et al. Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors. J Clin Oncol . 2006;24:945. 14. Ruggiero SL, Dodson TB, Fantasia J, et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw – 2014 update. J Oral Maxillofac Surg . 2014;72:1938-1956. 15. Albu IA, Petrovan C, Păcurar M, et

Open access
Magnetic Resonance Imaging of Myocardial Function Following Intracoronary and Intramyocardial Stem Cell Injection

superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer. BMC Cancer . 2012;12:284. 32. Guenoun J, Koning GA, Doeswijk G, et al. Cationic Gd-DTPA liposomes for highly efficient labeling of mesenchymal stem cells and cell tracking with MRI. Cell Transplant . 2012;21:191-205. 33. Mamani JB, Pavon LF, Miyaki LA, et al. Intracellular labeling and quantification process by magnetic resonance imaging using iron oxide magnetic nanoparticles in rat C6 glioma cell line. Einstein . 2012;10:216-221. 34. Vuong QL, Van

Open access
Use of Circulating and Cellular miRNAs Expression in Forensic Sciences

, Uchimoto ML, Coult N, World D, Beasley E, Avenell P. Characterisation of body fluid specific microRNA markers by capillary electrophoresis. Forensic Sci Int Genet Suppl Ser . 2013;4:e274-e275. 26. Kuner R, Brase JC, Sültmann H, Wuttig D: microRNA biomarkers in body fluids of prostate cancer patients. Methods . 2013;59:132-137. 27. Gilad S, Meiri E, Yogev Y, et al. Serum microRNAs are promising novel biomarkers. PLoS One . 2008;3:1-7. 28. Roth C, Rack B, Müller V, Janni W, Pantel K, Schwarzenbach H. Circulating microRNAs as blood-based markers for

Open access